卡特-T疗法的困境以及下一代创新的设计策略
Zhiwei Wang1,2, Peixian Li2, Xiaoyu Zeng2
1The First Affiliated Hospital of Henan University, 475004, Kaifeng, China.
Cell death & disease
|March 28, 2025
概括
化学抗原受体 (CAR) -T细胞疗法对血液癌症有希望,但面临挑战. 本综述探讨了跨学科的策略,以克服CAR-T细胞的局限性,以改善瘤免疫治疗.
科学领域:
- 免疫治疗是一种免疫疗法.
- 细胞疗法细胞疗法
- 合成生物学 合成生物学
背景情况:
- 化学抗原受体 (CAR) -T细胞疗法是一个快速增长的领域,在血液瘤中取得了显著的成功.
- 尽管取得了成功,但针对CD19的CAR-T细胞疗法仍面临局限性,包括限制贩运,瘤透和免疫抵抗.
研究的目的:
- 审查下一代CAR-T细胞设计和交付的跨学科战略.
- 解决限制当前CAR-T细胞疗法的有效性的关键障碍.
主要方法:
- 基于合成生物学的开启/关闭开关的探索.
- 生物指导性支架和纳米材料的整合.
- 型病毒的应用,CRISPR查和微生物组调制.
主要成果:
- 确定了多种创新技术来增强CAR-T细胞功能.
- 突出了克服细胞毒性和免疫抑制等挑战的战略.
- 为改善瘤向和功效提出解决方案.
结论:
- 跨学科的方法对于推进CAR-T细胞疗法至关重要.
- 下一代CAR-T细胞需要创新的设计和交付方法.
- 克服目前的局限性将扩大CAR-T细胞在癌症免疫治疗中的治疗潜力.
更多相关视频
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
1.5K
07:33Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy
Published on: September 19, 2025
1.0K
相关概念视频
00:59Gene Therapy
22.1K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
22.1K
01:27Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
01:28Structure-Activity Relationships and Drug Design
1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160
01:26Modeling in Therapy
823
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
823